Polymorphism in Epidermal Growth Factor Receptor Intron 1 Predicts Prognosis of Patients with Esophageal Cancer after Chemoradiation and Surgery

By Lee Jang-Ming  

Annals of Surgical Oncology, Vol. 18, Iss. 7, 2011-07 ,pp. : 2066-2073

Springer Publishing Company

Access to resources Recommend Favorite

Concurrent radiotherapy plus epidermal growth factor receptor inhibitors in patients with human papillomavirus-related head and neck cancer

By Pajares B.   Perez-Villa L.   Trigo J.   Toledo M.   Álvarez M.   Jimenez B.   Medina J.   Luque V.   Jerez J.   Alba E.  

Clinical and Translational Oncology, Vol. 16, Iss. 4, 2014-04 ,pp. : 418-424

Springer Publishing Company

Access to resources Recommend Favorite

Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy

By Kim Ji-Won   Kim Jee   Im Seock-Ah   Lee Kyung-Hun   Kim Jin-Soo   Kim Tae-Yong   Han Sae-Won   Jeon Yoon   Oh Do-Youn   Kim Tae-You   Park In  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1023-1029

Springer Publishing Company

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor and Prognosis in Colon Cancer: A Crack in the Wall?

By Ferrara Gerardo   Palombi Natalia   Di Blasi Arturo  

Annals of Surgical Oncology, Vol. 14, Iss. 7, 2007-07 ,pp. : 2169-2170

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

By Tsutsui S.  

Breast Cancer Research and Treatment, Vol. 71, Iss. 1, 2002-01 ,pp. : 67-75

Springer Publishing Company

Access to resources Recommend Favorite